Table II.

Cell cycle analysis in the blank, pCDH, pCDH-C/EBPβ, pLKO.1-shNC and pLKO.1-shC/EBPβ groups.

Group	G1 phase (%)	S phase (%)	G2 phase (%)
Blank	62.79±1.06	27.87±1.36	9.31±1.09
pCDH	64.83±1.69	28.18±1.35	8.42±0.75
pCDH-C/EBPβ	55.13±1.13a,b	26.21±1.95	18.67±0.73a,b
pLKO.1-shNC	66.08±3.50	27.91±1.02	5.75±0.62
pLKO.1-shC/EBPβ	91.62±2.83a,c	4.21±0.23a,c	4.13±0.29

^aP<0.05 vs. the blank group

^bP<0.05 vs. the pCDH group

^cP<0.05 vs. the pLKO.1-shNC group. C/EBPβ, CCAAT enhancer binding protein β; NC, negative control.